Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.

Michael R Pranzatelli; Elizabeth D Tate; Anna L Travelstead; Jerry Barbosa; Robert A Bergamini; Lucy Civitello; David N Franz; Brian S Greffe; Robin D Hanson; Craig A Hurwitz

doi:10.1097/01.mph.0000212991.64435.f0

Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.

Identifier:nobleid.org/w1/20260515/890141EC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/890141EC.svg?ark=w1%2F20260515%2F890141EC)](https://nobleid.org/work/w1/20260515/890141EC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Michael R Pranzatelli

Claim authorship of this work

Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome.

Identifier:nobleid.org/w1/20260515/890141EC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/890141EC.svg?ark=w1%2F20260515%2F890141EC)](https://nobleid.org/work/w1/20260515/890141EC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Michael R Pranzatelli

Claim authorship of this work